Samsung has announced a new app called Samsung Health Monitor for the Galaxy Watch Active 2 that allows users to monitor their blood pressure levels. The app has received certification from South Korea’s Ministry of Food and Drug Safety (MFDS) and has been granted the status of Software as a Medical Device (SaMD).

The Samsung Health Monitor app is compatible only with the Galaxy Watch Active 2 and upcoming models, and will be released in Q3 2020. It employs the heart rate sensors on the Samsung smartwatch to measure the change in blood flow volume for tracking blood pressure levels.

However, users will first have to measure their blood pressure using a medically certified BP cuff and then feed the reading inside the app, a process Samsung calls calibration. Users who have the Samsung Health Monitor app on their Galaxy Watch Active 2 will have to do the calibration every four weeks to monitor their blood pressure levels accurately.

Source: Samsung Newsroom

I’ve been writing about consumer technology for over three years now, having worked with names such as NDTV and Beebom in the past. Aside from covering the latest news, I’ve reviewed my fair share of devices ranging from smartphones and laptops to smart home devices. I also have interviewed tech execs and appeared as a host in YouTube videos talking about the latest and greatest gadgets out there.
You May Also Like
YouTube
YouTube testing ‘Premium Lite’, a cheaper tier without YouTube Music
YouTube is testing a more affordable Premium subscription in select European countries. It offers ad-free viewing but lacks YouTube Music.
TikTok algorithm featured
How TikTok works, insights into its algorithm
A former Google engineer who worked on YouTube’s algorithm has revealed that TikTok works very similarly, although it can be more extreme than YouTube.
Apple Watch size
Apple Watch Series 6, Samsung Galaxy Watch 3 and more watches are on sale
Check out the best deals on smartwatches available on Amazon.com, where we have the latest Apple Watch Series 6, Garmin watches, and more